By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AdkhabarAdkhabarAdkhabar
Notification Show More
Font ResizerAa
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Reading: Azerion Group publishes its 2025 Annual Report
Share
Font ResizerAa
AdkhabarAdkhabar
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Search
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Follow US
Adkhabar > Blog > Technology > Azerion Group publishes its 2025 Annual Report
Azerion Group publishes its 2025 Annual Report
Technology

Azerion Group publishes its 2025 Annual Report

GlobeNews Wire
Last updated: 17/04/2026 10:38 PM
GlobeNews Wire
Published: 17/04/2026
Share
SHARE

Azerion Group publishes its 2025 Annual Report 

Amsterdam, 17 April 2026 – Azerion Group N.V. (EURONEXT: AZRN) today published its audited 2025 Annual Report. The 2025 Annual Report has been filed with the Dutch Authority for the Financial Markets (the AFM) and is available at www.azerion.com/reports/ as a PDF file as well as in the ESEF (European Single Electronic Format) and HTML format.
The audited report is consistent with the preliminary full-year 2025 figures published on 26 February 2026, reporting revenues of € 540.6 million and an adjusted EBITDA of € 67.1 million for our continuing operations.

About Azerion
Founded in 2014, Azerion (EURONEXT: AZRN) is one of Europe’s largest digital advertising and entertainment media platforms. Azerion brings global scaled audiences to advertisers in an easy and cost-effective way, delivered through our proprietary technology, in a safe, engaging, and high-quality environment, utilising our strategic portfolio of owned and operated content with entertainment and other digital publishing partners.

Having its roots in Europe and with its headquarters in Amsterdam, Azerion has commercial teams based in 29 cities around the world to closely support our clients and partners to find and execute creative ways to make a real impact through advertising.

For more information visit: www.azerion.com

Contact:
Investor Relations
ir@azerion.com

Disclaimer

This communication is for information purposes only. The information contained in this communication does not purport to be full or complete and, in particular, is not intended to form the basis of any investment decision. No reliance must be placed by any person for any purpose on the information contained in this communication or its accuracy, fairness or completeness. Azerion is not liable for any loss or damages of any nature ensuing from using, trusting or acting on the information contained in this communication

  • Azerion Group publishes its 2025 Annual Report.docx
UAE Approves BioAros Longevity+ Supplement, Signaling Major Market Potential in Global Preventive Health
Financire de Tubize – 2025 half-year financial report
FemiCore (Official Website & Authenticity Notice 2026) Counterfeit Risks and What Consumers Should Know
Phoenix Aviation Capital and AIP Capital Announce Closing of Inaugural $550 Million Senior Unsecured Notes Offering
adidas reveals largest ever collection of home kits ahead of FIFA World Cup 2026
TAGGED:2025Amsterdam:AZRNannualazeriongroupitsnewsNL00150006Z9publishesreport
Share This Article
Facebook Email Print
- Advertisement -

Follow US

Find US on Social Medias
FacebookLike
XFollow
YoutubeSubscribe

Weekly Newsletter

Subscribe to our newsletter to get our newest articles instantly!
Popular News
Behind the Three-Year Dominance: Unilumin’s Counter-Cyclical Expansion
News

Behind the Three-Year Dominance: Unilumin’s Counter-Cyclical Expansion

29/04/2026
NYSE Content Advisory: Pre-Market update + Tax Firm Andersen Raises $176 Million in NYSE IPO
Varonis Announces Third Quarter 2025 Financial Results
Goyal Properties Launches Pune’s First Multi-Channel Brand Campaign Imagined on AI
Rhythm Pharmaceuticals Announces Additional Positive Data from Phase 3 TRANSCEND trial of Setmelanotide in Patients with Acquired Hypothalamic Obesity
- Advertisement -
- Advertisement -
- Advertisement -

Categories

  • Automobile
  • Entertainment
  • E-Sports
  • Food
  • Health
  • Technology
  • LifeStyle
  • Travel

About Us

Through our news networks, we raise millions of users' awareness. We are among the world's most reputable news networks.
Quick Link
Top Categories
  • Entertainment

Subscribe US

Subscribe to our newsletter to get our newest articles instantly!

AdkhabarAdkhabar
Copyright © 2021 - 2025 AdKhabar. All Rights Reserved. POWERED BY Life Care News.
Join Us!
Subscribe to our newsletter and never miss our latest news, podcasts etc..
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?